Bristol-Myers Squibb's market cap is currently CHF70.99B. The company's EPS TTM is CHF1.1617673476; its P/E ratio is 21.40; and it has a dividend yield of 1.82%. Bristol-Myers Squibb is scheduled to report earnings on August 1, 2025, and the estimated EPS forecast is CHF1.22. See an overview of income statement, balance sheet, and cash flow financials.
